Autism, gastrointestinal disturbance, and immune dysfunction: What is the link?

Autism: Oxidative Stress, Inflammation, and Immune Abnormalities

Volumn , Issue , 2009, Pages 277-298

  Ashwood, Paul ^a,b   Enstrom, Amanda ^a,b   Van de Water, Judy ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84904891081     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (137)

1. Afzal, N., S. Murch, K. Thirrupathy, L. Berger, A. Fagbemi, and R. Heuschkel. 2003. Constipation with acquired megarectum in children with autism. Pediatrics 112:939-942.
2. Anderson, G. M. 1987. Monoamines in autism: An update of neurochemical research on a pervasive developmental disorder. Med. Biol. 65:67-74.
3. APA. 2000. Diagnostic and Statistical Manual of Mental Disorders, 4th edition, text revision (DMS-IV-TR), Ed. APA. Arlington, VA: American Psychiatric Association Publishing, Inc.
4. Ashwood, P. and A. J. Wakefield. 2006. Immune activation of peripheral blood and mucosal CD3+ lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms. J. Neuroimmunol. 173:126-134.
5. Ashwood, P., A. Anthony, A. A. Pellicer, F. Torrente, J. A. Walker-Smith, and A. J. Wakefield. 2003. Intestinal lymphocyte populations in children with regressive autism: Evidence for extensive mucosal immunopathology. J. Clin. Immunol. 23:504-517.
6. Ashwood, P., A. Anthony, F. Torrente, and A. J. Wakefield. 2004. Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: mucosal immune activation and reduced counter regulatory interleukin-10. J. Clin. Immunol. 24:664-673.
7. Asperger, H. 1961. Psychopathology of children with coeliac disease. Ann. Paediatr. 197:346-351.
8. Bailey, A., A. Le Couteur, I. Gottesman, P. Bolton, E. Simonoff, E. Yuzda, and M. Rutter. 1995. Autism as a strongly genetic disorder: Evidence from a British twin study. Psychol. Med. 25:63-77.
9. Baird, G., H. Cass, and V. Slonims. 2003. Diagnosis of autism. BMJ 327:488-493.
10. Betancur, C., M. Leboyer, and C. Gillberg. 2002. Increased rate of twins among affected sibling pairs with autism. Am. J. Hum. Genet. 70:1381-1383.
11. Bjarnason, I., T. J. Peters, and N. Veall. 1983. Intestinal permeability defect in coeliac disease. Lancet 1:1284-1285.
12. Braunschweig, D., P. Ashwood, P. Krakowiak, I. Hertz-Picciotto, R. Hansen, L. A. Croen, I. N. Pessah, and J. Van de Water. 2008. Autism: Maternally derived antibodies specific for fetal brain proteins. Neurotoxicology 29:226-231.
13. Cabanlit, M., S. Wills, P. Goines, P. Ashwood, and J. Van de Water. 2007. Brain-specific autoantibodies in the plasma of subjects with autistic spectrum disorder. Ann. N.Y. Acad. Sci. 1107:92-103.
14. Cederlund, M. and C. Gillberg. 2004. One hundred males with Asperger syndrome: A clinical study of background and associated factors. Dev. Med. Child Neurol. 46:652-660.
15. Chess, S. 1971. Autism in children with congenital rubella. J. Autism Child Schizophr. 1:33-47.
16. Christison, G. W. and K. Ivany. 2006. Elimination diets in autism spectrum disorders: Any wheat amidst the chaff? J. Dev. Behav. Pediatr. 27:S162-171.
17. Comi, A. M., A. W. Zimmerman, V. H. Frye, P. A. Law, and J. N. Peeden. 1999. Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J. Child Neurol. 14:388-394.
18. Connolly, A. M., M. G. Chez, A. Pestronk, S. T. Arnold, S. Mehta, and R. K. Deuel. 1999. Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders. J. Pediatr. 134:607-613.
19. Connolly, A. M., M. Chez, E. M. Streif, R. M. Keeling, P. T. Golumbek, J. M. Kwon, J. J. Riviello, R. G. Robinson, R. J. Neuman, and R. M. Deuel. 2006. Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsy. Biol. Psychiatry 59:354-363.
20. Cook, E. H. and B. L. Leventhal. 1996. The serotonin system in autism. Curr. Opin. Pediatr. 8:348-354.
21. Cook, E. H., Jr., B. L. Leventhal, W. Heller, J. Metz, M. Wainwright, and D. X. Freedman. 1990. Autistic children and their first-degree relatives: Relationships between serotonin and norepinephrine levels and intelligence. J. Neuropsychiatry Clin. Neurosci. 2:268-274.
22. Cooke, W. T. and W. T. Smith. 1966. Neurological disorders associated with adult coeliac disease. Brain 89:683-722.
23. Croen, L. A., J. K. Grether, C. K. Yoshida, R. Odouli, and J. Van de Water. 2005. Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: A case-control study. Arch. Pediatr. Adolesc. Med. 159:151-157.
24. Croonenberghs, J., E. Bosmans, D. Deboutte, G. Kenis, and M. Maes. 2002. Activation of the inflammatory response system in autism. Neuropsychobiology 45:1-6.
25. Cummins, A. G., I. A. Penttila, J. T. Labrooy, T. A. Robb, and G. P. Davidson. 1991. Recovery of the small intestine in coeliac disease on a gluten-free diet: Changes in intestinal permeability, small bowel morphology and T-cell activity. J. Gastroenterol. Hepatol. 6:53-57.
26. D’Eufemia, P., M. Celli, R. Finocchiaro, L. Pacifico, L. Viozzi, M. Zaccagnini, E. Cardi, and O. Giardini. 1996. Abnormal intestinal permeability in children with autism. Acta Paediatr. 85:1076-1079.
27. Dalton, P., R. Deacon, A. Blamire, M. Pike, I. McKinlay, J. Stein, P. Styles, and A. Vincent. 2003. Maternal neuronal antibodies associated with autism and a language disorder. Ann. Neurol. 53:533-537.
28. Denney, D. R., B. W. Frei, and G. R. Gaffney. 1996. Lymphocyte subsets and interleukin-2 receptors in autistic children. J. Autism Dev. Disord. 26:87-97.
29. Dunn, A. J. 2006. Effects of cytokines and infections on brain neurochemistry. Clin. Neurosci. Res. 6:52-68.
30. Elder, J. H., M. Shankar, J. Shuster, D. Theriaque, S. Burns, and L. Sherrill. 2006. The gluten-free, casein-free diet in autism: Results of a preliminary double blind clinical trial. J. Autism Dev. Disord. 36:413-420.
31. Enstrom, A. M., L. Lit, C. E. Onore, J. P. Gregg, R. Hansen, I. N. Pessah, I. Hertz-Picciotto, J. A. Van de Water, F. R. Sharp, and P. Ashwood. 2009. Altered gene expression and function of peripheral blood natural killer cells in children with autism. Brain Behav. Immun. 23(1):124-133.
32. Ercolini, A. M. and S. D. Miller. 2005. Role of immunologic cross-reactivity in neurological diseases. Neurol. Res. 27:726-733.
33. Erickson, C. A., K. A. Stigler, M. R. Corkins, D. J. Posey, J. F. Fitzgerald, and C. J. McDougle. 2005. Gastrointestinal factors in autistic disorder: A critical review. J. Autism Dev. Disord. 35:713-727.
34. Fasano, A. 2001. Intestinal zonulin: Open sesame! Gut 49:159-162.
35. Fasano, A. and C. Catassi. 2005. Coeliac disease in children. Best Pract. Res. Clin. Gastroenterol. 19:467-478.
36. Fasano, A. and T. Shea-Donohue. 2005. Mechanisms of disease: The role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases. Nat. Clin. Pract. Gastroenterol. Hepatol. 2:416-422.
37. Fasano, A., T. Not, W. Wang, S. Uzzau, I. Berti, A. Tommasini, and S. E. Goldblum. 2000. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet 355:1518-1519.
38. Ferrante, P., M. Saresella, F. R. Guerini, M. Marzorati, M. C. Musetti, and A. G. Cazzullo. 2003. Significant association of HLA A2-DR11 with CD4 naive decrease in autistic children. Biomed. Pharmacother. 57:372-374.
39. Fiumara, A., A. Sciotto, R. Barone, G. D’Asero, S. Munda, E. Parano, and L. Pavone. 1999. Peripheral lymphocyte subsets and other immune aspects in Rett syndrome. Pediatr. Neurol. 21:619-621.
40. Folstein, S. and M. Rutter. 1977. Infantile autism: A genetic study of 21 twin pairs. J. Child Psychol. Psychiatry 18:297-321.
41. Fombonne, E. 1999. Are measles infections or measles immunizations linked to autism? J. Autism Dev. Disord. 29:349-350.
42. Furlano, R. I., A. Anthony, R. Day, A. Brown, L. McGarvey, M. A. Thomson, S. E. Davies, M. Berelowitz, A. Forbes, A. J. Wakefield, J. A. Walker-Smith, and S. H. Murch. 2001. Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism. J. Pediatr. 138:366-372.
43. Gillberg, C. and M. Coleman. 2000. The Biology of Autistic Syndromes, 3rd edition. London, U.K.: Mac Keith Press distributed by Cambridge University Press.
44. Glasson, E. J., C. Bower, B. Petterson, N. de Klerk, G. Chaney, and J. F. Hallmayer. 2004. Perinatal factors and the development of autism: A population study. Arch. Gen. Psychiatry 61:618-627.
45. Gordon, C. T., R. C. State, J. E. Nelson, S. D. Hamburger, and J. L. Rapoport. 1993. A doubleblind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Arch. Gen. Psychiatry 50:441-447.
46. Graus, F., B. Lang, P. Pozo-Rosich, A. Saiz, R. Casamitjana, and A. Vincent. 2002. PGQ type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer. Neurology 59:764-766.
47. Greenberg, D. A., S. E. Hodge, J. Sowinski, and D. Nicoll. 2001. Excess of twins among affected sibling pairs with autism: Implications for the etiology of autism. Am. J. Hum. Genet. 69:1062-1067.
48. Guggenmos, J., A. S. Schubart, S. Ogg, M. Andersson, T. Olsson, I. H. Mather, and C. Linington. 2004. Antibody cross-reactivity between myelin oligodendrocyte glycoprotein and the milk protein butyrophilin in multiple sclerosis. J. Immunol. 172:661-668.
49. Gupta, S., S. Aggarwal, B. Rashanravan, and T. Lee. 1998. Th1- and Th2-like cytokines in CD4G and CD8 T cells in autism. J. Neuroimmunol. 85:106-109.
50. Hadjivassiliou, M., R. A. Grunewald, and G. A. Davies-Jones. 2002. Gluten sensitivity as a neurological illness. J. Neurol. Neurosurg. Psychiatry 72:560-563.
51. Hallert, C. and T. Derefeldt. 1982. Psychic disturbances in adult coeliac disease. I. Clinical observations. Scand. J. Gastroenterol. 17:17-19.
52. Hellings, J. A., L. A. Kelley, W. F. Gabrielli, E. Kilgore, and P. Shah. 1996. Sertraline response in adults with mental retardation and autistic disorder. J. Clin. Psychiatry 57:333-336.
53. Hellings, J. A., J. R. Zarcone, R. M. Reese, M. G. Valdovinos, J. G. Marquis, K. K. Fleming, and S. R. Schroeder. 2006. A crossover study of risperidone in children, adolescents and adults with mental retardation. J. Autism Dev. Disord. 36:401-411.
54. Hoekstra, P. J. and R. B. Minderaa. 2005. Tic disorders and obsessive-compulsive disorder: Is autoimmunity involved? Int. Rev. Psychiatry 17:497-502.
55. Horvath, K. and J. A. Perman. 2002a. Autism and gastrointestinal symptoms. Curr. Gastroenterol. Rep. 4:251-258.
56. Horvath, K. and J. A. Perman. 2002b. Autistic disorder and gastrointestinal disease. Curr. Opin. Pediatr. 14:583-587.
57. Horvath, K., J. C. Papadimitriou, A. Rabsztyn, C. Drachenberg, and J. T. Tildon. 1999. Gastrointestinal abnormalities in children with autistic disorder. J. Pediatr. 135:559-563.
58. Hyman, S. L. and S. E. Levy. 2005. Introduction: Novel therapies in developmental disabilities-hope, reason, and evidence. Ment. Retard. Dev. Disabil. Res. Rev. 11:107-109.
59. Jyonouchi, H., S. Sun, and H. Le. 2001. Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J. Neuroimmunol. 120:170-179.
60. Jyonouchi, H., L. Geng, A. Ruby, and B. Zimmerman-Bier. 2005. Dysregulated innate immune responses in young children with autism spectrum disorders: Their relationship to gastrointestinal symptoms and dietary intervention. Neuropsychobiology 51:77-85.
61. Kalat, J. W. 1978. Speculations on similarities between autism and opiate addiction. J. Autism Child Schizophr. 8:477-479.
62. Kim, S. J., N. Cox, R. Courchesne, C. Lord, C. Corsello, N. Akshoomoff, S. Guter, B. L. Leventhal, E. Courchesne, and E. H. Cook, Jr. 2002. Transmission disequilibrium mapping at the serotonin transporter gene (SLC6A4) region in autistic disorder. Mol. Psychiatry 7:278-288.
63. Knivsberg, A. M., K. L. Reichelt, and M. Nodland. 2001. Reports on dietary intervention in autistic disorders. Nutr. Neurosci. 4:25-37.
64. Kozlovskaia, G. V., T. P. Kliushnik, A. V. Goriunova, I. L. Turkova, M. A. Kalinina, and N. S. Sergienko. 2000. Nerve growth factor auto-antibodies in children with various forms of mental dysontogenesis and in schizophrenia high risk group. Zh. Nevrol. Psikhiatr. Im. S. S. Korsakova 100:50-52.
65. Kuddo, T. and K. B. Nelson. 2003. How common are gastrointestinal disorders in children with autism? Curr. Opin. Pediatr. 15:339-343.
66. Lang, B., R. C. Dale, and A. Vincent. 2003. New autoantibody mediated disorders of the central nervous system. Curr. Opin. Neurol. 16:351-357.
67. Larson, S. J. 2002. Behavioral and motivational effects of immune-system activation. J. Gen. Psychol. 129:401-414.
68. Lee, L. C., A. A. Zachary, M. S. Leffell, C. J. Newschaffer, K. J. Matteson, J. D. Tyler, and A. W. Zimmerman. 2006. HLA-DR4 in families with autism. Pediatr. Neurol. 35:303-307.
69. Levy, S. E., M. C. Souders, R. F. Ittenbach, E. Giarelli, A. E. Mulberg, and J. A. Pinto-Martin. 2007. Relationship of dietary intake to gastrointestinal symptoms in children with autistic spectrum disorders. Biol. Psychiatry 61:492-497.
70. Licinio, J., M. A. Kling, and P. Hauser. 1998. Cytokines and brain function: Relevance to interferon-alpha-induced mood and cognitive changes. Semin. Oncol. 25:30-38.
71. Lightdale, J. R., C. Hayer, A. Duer, C. Lind-White, S. Jenkins, B. Siegel, G. R. Elliott, and M. B. Heyman. 2001. Effects of intravenous secretin on language and behavior of children with autism and gastrointestinal symptoms: A single-blinded, open-label pilot study. Pediatrics 108:E90.
72. Liu, Z., N. Li, and J. Neu. 2005. Tight junctions, leaky intestines, and pediatric diseases. Acta Paediatr. 94:386-393.
73. Martin, L. A., P. Ashwood, D. Braunschweig, M. Cabanlit, J. Van de Water, and D. G. Amaral. 2008. Stereotypies and hyperactivity in rhesus monkeys exposed to IgG from mothers of children with autism. Brain Behav. Immun. 22:806-816.
74. McDougle, C. J., J. P. Holmes, D. C. Carlson, G. H. Pelton, D. J. Cohen, and L. H. Price. 1998. A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders. Arch. Gen. Psychiatry 55:633-641.
75. Melmed, R.D., C.K. Schneider, R.A. Fabes, J. Phillips, and K. Reichelt. 2000. Metabolic markers and gastrointestinal symptoms in children with autism and related disorders. J. Pediatr. Gastroenterol. Nutr. 31:S31-S32.
76. Meyer, U., M. Nyffeler, A. Engler, A. Urwyler, M. Schedlowski, I. Knuesel, B. K. Yee, and J. Feldon. 2006. The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J. Neurosci. 26:4752-4762.
77. Millward, C., M. Ferriter, S. Calver, and G. Connell-Jones. 2008. Gluten- and casein-free diets for autistic spectrum disorder. Cochrane Database Syst. Rev. CD003498.
78. Ming, X., M. Brimacombe, J. Chaaban, B. Zimmerman-Bier, and G. C. Wagner. 2008. Autism spectrum disorders: Concurrent clinical disorders. J. Child Neurol. 23:6-13.
79. Molloy, C. A. and P. Manning-Courtney. 2003. Prevalence of chronic gastrointestinal symptoms in children with autism and autistic spectrum disorders. Autism 7:165-171.
80. Molloy, C. A., A. L. Morrow, J. Meinzen-Derr, K. Schleifer, K. Dienger, P. Manning-Courtney, M. Altaye, and M. Wills-Karp. 2006. Elevated cytokine levels in children with autism spectrum disorder. J. Neuroimmunol. 172:198-205.
81. Money, J., N. A. Bobrow, and F. C. Clarke. 1971. Autism and autoimmune disease: A family study. J. Autism Child Schizophr. 1:146-160.
82. Mouridsen, S. E., B. Rich, T. Isager, and N. J. Nedergaard. 2007. Autoimmune diseases in parents of children with infantile autism: A case-control study. Dev. Med. Child Neurol. 49:429-432.
83. Muhle, R., S. V. Trentacoste, and I. Rapin. 2004. The genetics of autism. Pediatrics 113: e472-e486.
84. Muller, N. and M. Ackenheil. 1998. Psychoneuroimmunology and the cytokine action in the CNS: Implications for psychiatric disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry 22:1-33.
85. Murinson, B. B. and A. Vincent. 2001. Stiff-person syndrome: Autoimmunity and the central nervous system. CNS Spectr. 6:427-433.
86. Nawa, H., M. Takahashi, and P. H. Patterson. 2000. Cytokine and growth factor involvement in schizophrenia: Support for the developmental model. Mol. Psychiatry 5:594-603.
87. Niehus, R. and C. Lord. 2006. Early medical history of children with autism spectrum disorders. J. Dev. Behav. Pediatr. 27:S120-S127.
88. Panksepp, J. 1979. Neurochemical theory of autism. Trends Neurosci. 2:174-177.
89. Parracho, H. M., M. O. Bingham, G. R. Gibson, and A. L. McCartney. 2005. Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J. Med. Microbiol. 54:987-991.
90. Plioplys, A. V., A. Greaves, K. Kazemi, and E. Silverman. 1994. Lymphocyte function in autism and Rett syndrome. Neuropsychobiology 29:12-16.
91. Ringel, Y. and D. A. Drossman. 2001. Psychosocial aspects of Crohn’s disease. Surg. Clin. North Am. 81:231-252.
92. Ringel, Y. and D. A. Drossman. 2002. Irritable bowel syndrome: Classification and conceptualization. J. Clin. Gastroenterol. 35:S7-S10.
93. Rogers, S. W., P. I. Andrews, L. C. Gahring, T. Whisenand, K. Cauley, B. Crain, T. E. Hughes, S. F. Heinemann, and J. O. McNamara. 1994. Autoantibodies to glutamate receptor GluR3 in Rasmussen’s encephalitis. Science 265:648-651.
94. Rosen, N. J., C. K. Yoshida, and L. A. Croen. 2007. Infection in the first 2 years of life and autism spectrum disorders. Pediatrics 119:61-69.
95. Singer, H. S., C. M. Morris, P. N. Williams, D. Y. Yoon, J. J. Hong, and A. W. Zimmerman. 2006. Antibrain antibodies in children with autism and their unaffected siblings. J. Neuroimmunol. 178:149-155.
96. Singer, H. S., C. M. Morris, C. D. Gause, P. K. Gillin, S. Crawford, and A. W. Zimmerman. 2008. Antibodies against fetal brain in sera of mothers with autistic children. J. Neuroimmunol. 194:165-172.
97. Singh, V. K. 1996. Plasma increase of interleukin-12 and interferon-gamma. Pathological significance in autism. J. Neuroimmunol. 66:143-145.
98. Singh, V. K. and W. H. Rivas. 2004. Prevalence of serum antibodies to caudate nucleus in autistic children. Neurosci. Lett. 355:53-56.
99. Singh, V. K., E. A. Singh, and R. P. Warren. 1997. Hyperserotoninemia and serotonin receptor antibodies in children with autism but not mental retardation. Biol. Psychiatry 41:753-755.
100. Singh, V. K., S. Mehrotra, and S. S. Agarwal. 1999. The paradigm of Th1 and Th2 cytokines: its relevance to autoimmunity and allergy. Immunol. Res. 20:147-161.
101. Singh, V. K., R. P. Warren, J. D. Odell, W. L. Warren, and P. Cole. 1993. Antibodies to myelin basic protein in children with autistic behavior. Brain Behav. Immun. 7:97-103.
102. Singh, V. K., R. Warren, R. Averett, and M. Ghaziuddin. 1997. Circulating autoantibodies to neuronal and glial filament proteins in autism. Pediatr. Neurol. 17:88-90.
103. Smith, S. E., J. Li, K. Garbett, K. Mirnics, and P. H. Patterson. 2007. Maternal immune activation alters fetal brain development through interleukin-6. J. Neurosci. 27:10695-10702.
104. Spiller, R. C., D. Jenkins, J. P. Thornley, J. M. Hebden, T. Wright, M. Skinner, and K. R. Neal. 2000. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 47:804-811.
105. Stahl, S. M. 1977. The human platelet. A diagnostic and research tool for the study of biogenic amines in psychiatric and neurologic disorders. Arch. Gen. Psychiatry 34:509-516.
106. Stubbs, E. G. and M. L. Crawford. 1977. Depressed lymphocyte responsiveness in autistic children. J. Autism Child Schizophr. 7:49-55.
107. Sweeten, T. L., D. J. Posey, and C. J. McDougle. 2003. High blood monocyte counts and neopterin levels in children with autistic disorder. Am. J. Psychiatry 160:1691-1693.
108. Sweeten, T. L., S. L. Bowyer, D. J. Posey, G. M. Halberstadt, and C. J. McDougle. 2003. Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. Pediatrics 112:e420.
109. Sweeten, T. L., D. J. Posey, S. Shankar, and C. J. McDougle. 2004. High nitric oxide production in autistic disorder: A possible role for interferon-gamma. Biol. Psychiatry 55:434-437.
110. Taniai, H., T. Nishiyama, T. Miyachi, M. Imaeda, and S. Sumi. 2008. Genetic influences on the broad spectrum of autism: Study of proband-ascertained twins. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 147B: 844-849.
111. Todd, R. D. and R. D. Ciaranello. 1985. Demonstration of inter- and intraspecies differences in serotonin binding sites by antibodies from an autistic child. Proc. Natl. Acad. Sci. U.S.A. 82:612-616.
112. Todd, R. D., J. M. Hickok, G. M. Anderson, and D. J. Cohen. 1988. Antibrain antibodies in infantile autism. Biol. Psychiatry 23:644-647.
113. Tohmi, M., N. Tsuda, Y. Watanabe, A. Kakita, and H. Nawa. 2004. Perinatal inflammatory cytokine challenge results in distinct neurobehavioral alterations in rats: Implication in psychiatric disorders of developmental origin. Neurosci. Res. 50:67-75.
114. Torrente, F., P. Ashwood, R. Day, N. Machado, R. I. Furlano, A. Anthony, S. E. Davies, A. J. Wakefield, M. A. Thomson, J. A. Walker-Smith, and S. H. Murch. 2002. Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism. Mol. Psychiatry 7:375-382, 334.
115. Torrente, F., A. Anthony, R. B. Heuschkel, M. A. Thomson, P. Ashwood, and S. H. Murch. 2004. Focal-enhanced gastritis in regressive autism with features distinct from Crohn’s and Helicobacter pylori gastritis. Am. J. Gastroenterol. 99:598-605.
116. Torres, A. R., T. L. Sweeten, A. Cutler, B. J. Bedke, M. Fillmore, E. G. Stubbs, and D. Odell. 2006. The association and linkage of the HLA-A2 class I allele with autism. Hum. Immunol. 67:346-351.
117. Valicenti-McDermott, M., K. McVicar, I. Rapin, B. K. Wershil, H. Cohen, and S. Shinnar. 2006. Frequency of gastrointestinal symptoms in children with autistic spectrum disorders and association with family history of autoimmune disease. J. Dev. Behav. Pediatr. 27:S128-S136.
118. Vargas, D. L., C. Nascimbene, C. Krishnan, A. W. Zimmerman, and C. A. Pardo. 2005. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann. Neurol. 57:67-81.
119. Vereker, E., E. O’Donnell, and M. A. Lynch. 2000. The inhibitory effect of interleukin-1beta on long-term potentiation is coupled with increased activity of stress-activated protein kinases. J. Neurosci. 20:6811-6819.
120. Vojdani, A., A. W. Campbell, E. Anyanwu, A. Kashanian, K. Bock, and E. Vojdani. 2002. Antibodies to neuron-specific antigens in children with autism: Possible cross-reaction with encephalitogenic proteins from milk, Chlamydia pneumoniae and Streptococcus group A. J. Neuroimmunol. 129:168-177.
121. Wakefield, A. J. 2002. The gut-brain axis in childhood developmental disorders. J. Pediatr. Gastroenterol. Nutr. 34(Suppl. 1): S14-S17.
122. Wakefield, A. J., A. Anthony, S. H. Murch, M. Thomson, S. M. Montgomery, S. Davies, J. J. O’Leary, M. Berelowitz, and J. A. Walker-Smith. 2000. Enterocolitis in children with developmental disorders. Am. J. Gastroenterol. 95:2285-2295.
123. Wakefield, A.J., P. Ashwood, K. Limb, and A. Anthony. 2005. The significance of ileo-colonic lymphoid nodular hyperplasia in children with autistic spectrum disorder. Eur. J. Gastroenterol. 17:827-836.
124. Walker-Smith J. and J. Andrews. 1972. Alpha-1-antitrypsin, autism, and coeliac disease. Lancet 2:883-884.
125. Wang, W., S. Uzzau, S. E. Goldblum, and A. Fasano. 2000. Human zonulin, a potential modulator of intestinal tight junctions. J. Cell. Sci. 113 (Pt. 24): 4435-4440.
126. Warren, R. P., A. Foster, and N. C. Margaretten. 1987. Reduced natural killer cell activity in autism. J. Am. Acad. Child Adolesc. Psychiatry 26:333-335.
127. Warren, R. P., J. D. Odell, W. L. Warren, R. A. Burger, A. Maciulius, W. W. Daniels, and A. R. Torres. 1996. Strong association of the third hypervariable region of HLA-DR beta 1 with autism. J. Neuroimmunol. 67:259-274.
128. Warren, R. P., L. J. Yonk, R. A. Burger, P. Cole, J. D. Odell, W. L. Warren, E. White, and V. K. Singh. 1990. Deficiency of suppressor-inducer (CD4h CD45RA) T cells in autism. Immunol. Invest. 19:245-251.
129. Warren, R. P., V. K. Singh, P. Cole, J. D. Odell, C. B. Pingree, W. L. Warren, C. W. DeWitt, and M. McCullough. 1992. Possible association of the extended MHC haplotype B44-SC30-DR4 with autism. Immunogenetics 36:203-207.
130. Warren, R. P., J. Yonk, R. W. Burger, D. Odell, and W. L. Warren. 1995. DR-positive T cells in autism: Association with decreased plasma levels of the complement C4B protein. Neuropsychobiology 31:53-57.
131. Watts, T., I. Berti, A. Sapone, T. Gerarduzzi, T. Not, R. Zielke, and A. Fasano. 2005. Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats. Proc. Natl. Acad. Sci. U.S.A. 102:2916-2921.
132. Weizman, A., R. Weizman, G. A. Szekely, H. Wijsenbeek, and E. Livni. 1982. Abnormal immune response to brain tissue antigen in the syndrome of autism. Am. J. Psychiatry 139:1462-1465.
133. Welch, M. G., T. B. Welch-Horan, M. Anwar, N. Anwar, R. J. Ludwig, and D. A. Ruggiero. 2005. Brain effects of chronic IBD in areas abnormal in autism and treatment by single neuropeptides secretin and oxytocin. J. Mol. Neurosci. 25:259-274.
134. White, J. F. 2003. Intestinal pathophysiology in autism. Exp. Biol. Med. 228:639-649.
135. Wills, S., M. Cabanlit, J. Bennett, P. Ashwood, D. Amaral, and J. Van de Water. 2007. Autoantibodies in autism spectrum disorders (ASD). Ann. N.Y. Acad. Sci. 1107:79-91.
136. Yamada, K., R. Iida, Y. Miyamoto, K. Saito, K. Sekikawa, M. Seishima, and T. Nabeshima. 2000. Neurobehavioral alterations in mice with a targeted deletion of the tumor necrosis factor-alpha gene: Implications for emotional behavior. J. Neuroimmunol. 111:131-138.
137. Yonk, L. J., R. P. Warren, R. A. Burger, P. Cole, J. D. Odell, W. L. Warren, E. White, and V. K. Singh. 1990. CD4K helper T cell depression in autism. Immunol. Lett. 25:341-345.